SAN CLEMENTE, Calif.,
Feb. 15, 2017 /PRNewswire/
-- ICU Medical, Inc. (NASDAQ: ICUI), a leader in innovative
medical devices for infusion therapy, oncology and critical care,
today announced results of a new multi-hospital study that shows
dramatic improvements in potentially catastrophic dosing errors
(PCDE) and drug library compliance when its Plum®
infusion pumps and Hospira MedNet® safety software are
integrated with hospitals' electronic medical records (EMR).
Results of the study will be featured in the company's booth #1053
at the HIMSS '17 Conference and Exhibition February 19-23 in Orlando.
The study showed a 52 percent decrease in the rate of PCDE's and
an average of 156 overall average percent increase in compliance
with a participating hospital's drug libraries after smart pump-EMR
integration, which was consistent across hospitals and sustained
after integration. One hospital saw a decrease in the PCDE rate of
as much as 73 percent. There was also a large and statistically
significant reduction in the variability in the severity of
individual PCDEs. PCDEs are defined as initial programmed doses of
intravenous medications considered 'High Alert'
medicationsi by the Institute of Safe Medication
Practices (ISMP) that were either 100 percent greater than or 50
percent less than the final programmed doses.
The study was performed at three US community hospitals ranging
from 50 to 350 beds integrating a Cerner Millennium™ EMR with ICU
Medical's Plum® smart infusion system using Hospira
MedNet safety software. More than 500,000 programming sequences
were examined as part of the study. The primary outcome showed the
impact of clinical integration of infusion devices with the EMR on
reducing serious, preventable medication errors. All three
metrics—incidence rate, compliance, and variability of
severity—improved at each individual hospital. When analyzing data
month by month over the study period, the reduction in PCDEs
clearly pivoted around the "Go-live" date and is sustained after
integration. A white paper detailing the study can be viewed
here.
"Both the reduced range of variance of PCDEs and the narrower
confidence intervals in the post integration data demonstrate that
variability in programming is greatly reduced after integration,"
explained Valerie King, MS, BSN,
HumD, one of the study authors. "Successful integration of infusion
devices and hospitals' EMR enables healthcare providers to ensure
the "Five Rights" verification—right patient, medication, dose,
time and route."
About ICU Medical, Inc.
About ICU Medical, Inc.
(Nasdaq:ICUI) develops, manufactures and sells innovative medical
devices used in vascular therapy, oncology and critical care
applications. ICU Medical's product portfolio includes IV smart
pumps, sets, connectors and solutions along with pain management
and safety software technology designed to help meet clinical,
safety and workflow goals. In addition, the company manufactures
automated pharmacy compounding systems with workflow technology,
closed systems transfer devices for hazardous drugs, disposable
blood pressure transducers, advanced sensor catheters, and cardiac
monitoring systems. ICU Medical is headquartered in San Clemente, California. More information
about ICU Medical, Inc. can be found at www.icumed.com.
Media Contact:
Tom
McCall, ICU Medical, Inc.
949-366-4368
tmccall@icumed.com
i
|
Institute for Safe
Medication Practices (ISMP). ISMP List of High-Alert Medication in
Acute Care Settings [web page]. Created 2014. Available at
https://www.ismp.org/Tools/highalertmedications.pdf. Accessed
May 16, 2016.
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/integrating-icu-medical-infusion-devices-with-hospital-electronic-medical-records-decreased-major-dosing-errors-by-52-percent-300407663.html
SOURCE ICU Medical, Inc.